Study of Efficacy of OXN PR, Compared to Oxy PR, for Reduction of Intensity of Opioid-induced Constipation Symptoms in patients Treated for Cancer or Non-cancer Pain: A Randomised, Double-blind, Controlled, Multicentre Study.

Trial Profile

Study of Efficacy of OXN PR, Compared to Oxy PR, for Reduction of Intensity of Opioid-induced Constipation Symptoms in patients Treated for Cancer or Non-cancer Pain: A Randomised, Double-blind, Controlled, Multicentre Study.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 30 Sep 2015

At a glance

  • Drugs Oxycodone; Oxycodone/naloxone
  • Indications Back pain; Cancer pain; Constipation; Musculoskeletal pain; Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jul 2012 Napp Pharmaceutical Group added as associations as reported in the European Clinical Trials Database record.
    • 15 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 07 Jun 2011 Planned end date (May 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top